# 2026-11-04 09:00 UTC — daily discussion

## State check

- Repo synced cleanly: `git checkout main` + `tools/git_sync.py` fast-forward,
  no divergence, no shallow-clone staleness.
- `AGENTS.md`'s "Current state" log is current through the ~06:47-07:23 UTC
  evolve batch today (cumulative candidates tried against v3: 99966,
  stagnation/boldness counter 7244). Nothing has happened since — no run
  note newer than `runs/2026-11-04-0723-evolve-batch-v3.md` exists at the
  start of this session, and this session made no state-changing calls
  before writing this note.
- Genome still v3 (1d) live, unchanged since its 2026-08-16 promotion.
  `review-hard-calls`: 0 pending (6 reviewed, all `approve`) — confirmed
  directly this cycle, not just read from the log. Constitution checksum
  verified (`726dfa4bac85891a`) on startup, no modification.
- `AGENTS.md` size 238,518 bytes — comfortably under the 256KB single-read
  threshold, no rotation needed this cycle.

## Anything needing the owner's attention?

No. Both items still open in "Owner decisions pending" / the numbered
"Next steps" list are unchanged since they were last written up, and
neither has a new trigger:

- **Item 6 (equities/FX data source)**: still blocked on a human picking
  Alpaca vs. a free historical mirror. Nothing to add — no code has a
  reason to exist yet without that choice.
- **Item 13 (`HOLDOUT_SIGMA`'s never-resetting cumulative correction)**: the
  2026-10-10 design pass already quantified the bounded alternatives
  (status quo / rolling window / full reset) and left the risk-appetite
  call with the owner, with effect sizes attached. Growth since then
  continues to track exactly as mild as that pass projected — margin was
  ~7.738 (draw ~1780) a day ago per the evolve-batch logs, now ~7.745 (draw
  1804) as of the latest recorded `holdout-pressure` check this morning —
  nowhere near forcing a decision on its own. Nothing new to report.

Routine work (3-hourly `evolve` batches, daily tick) continues on schedule
with no promotions, no idempotency violations, no constitution-checksum
issues, and no new findings since the last daily discussion
(`runs/2026-11-03-0900-daily-discussion.md`) reached the same "nothing new"
conclusion. Item 5 (short selling signal research) remains the only active
open-ended research thread, and the long-running `evolve`-batch cadence
against the still-undefeated v3 champion is otherwise unremarkable this
cycle.
